PMS17 BUDGET IMPACT OF NEW RHBMP-2 FORMULATION IN PATIENTS UNDERGOING POSTEROLATERAL SPINAL FUSION PROCEDURES FOR DEGENERATIVE DISC DISEASE IN RANDOMIZED CONTROLLED TRIAL (RCT)
Abstract
Authors
MM McInnis N Olchanski JE Kemner T Goss